Mayukh Sukhatme - Apr 20, 2022 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
Pres & Chief Investment Officer
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Mayukh Sukhatme
Stock symbol
ROIV
Transactions as of
Apr 20, 2022
Transactions value $
$0
Form type
4
Date filed
4/22/2022, 07:31 PM
Previous filing
Oct 1, 2021
Next filing
May 31, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ROIV Stock Option (Right to Buy) Award $0 +16.5M $0.00 16.5M Apr 20, 2022 Common Shares 16.5M $3.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2022. These options vest and become exercisable (i) 25% on the first anniversary of the applicable vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject generally to the reporting person's continuous service through each vesting date (unless otherwise provided in the applicable award documentation).

Remarks:

Pres & Chief Investment Officer